Korelasi Ekspresi Cyclooxygenase-2 Dengan Microvessel Density Pada Karsinoma Nasofaring Di RSUP H. Adam Malik Medan

  Asahara, T, Masuda, H, Takahashi T, Kalka, C, Pastore, C, Silver, M, Kearne, M, Magner, M, Isner, JM 1999, ‘Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization’ Circulation

  Research. 85 (3) pp.221-228.

  Agulnik, M & Siu, LL 2005, ‘State of the Art Management of Nasopharyngeal Carcinoma : Current and Future Directions’ British Journal of Cancer. 92 pp. 799-806.

  Andrianto Y 2008, Peranan Pemeriksaan Immunohistokimia COX-2 pada

  

Karsinoma Nasofaring. Tesis. Bagian Patologi Anatomi Fakultas

Kedokteran Universitas Sumatera Utara. Medan.

  Bono, AV, Celato, N, Cova, VM, Salvadore, M, Chinetti, S, & Novario, R 2002, ‘Microvessel density in Prostate Carcinoma’ Prostate Cancer and Prostatic Disease. 5 pp. 123-127.

  Brennan, B 2006, ‘Nasopharyngeal Carcinoma’ Orphanet Journal of Rare Diseases. 1 (23) pp.1-5. Chew, CT 1997, ‘Nasopharynx (The Postnasal Space)’ In : Hibbert, J. (ed)

  Laryngology and Head and Neck Surgery Scott-Brown’s th

  

Otolaryngology. 6 ed. London: Butterworth Heinemann. pp. 5/13/1-

29.

  Chien, CR, Chen, SW, Hsieh, CY & Liang, JA 2001, ‘Retrospective comparison of the AJCC, 5 th edition classification for nasopharyngeal

  th

  carcinoma with the AJCC 4 edition. An experience in Taiwan’ Japanese Journal of Clinical Oncology. 31(8) pp.363-9. Cho, WC, 2007 ‘Nasopharyngeal carcinoma : Molecular biomarker discovery and progress’ Molecular Cancer. 6 (1) pp.1-9. Choi, WWL, Lewis, MM, Lawson, D, Yin-Goen, Q, Birdsong, GG,

  Cotsonis, GA, Cohen C, and You, AN 2005, ‘Angiogenic and lymphangiogenic microvessel density in Breast Carcinoma : Correlation with Clinicopathologic Parameters and VEGF Family Gene Expression’

  Modern Pathology. 18 pp.143-152.

  Choy H & Milas L 2003, ‘Enhancing Radiotherapy with Cyclooxygenase-2 Enzym Inhibitors: A Rational Advance?. Journal of the National Cancer Institute. 95 (19): 1440-52.

  Clària, J. 2003, ‘Cyclooxygenase-2 Biology’ Current Pharmaceutical

  Design. 9. pp. 2177-2190

   stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment’ Clin Invest.. 113(7) pp.1040-50.

  Divvela, AKC, Challa, SR & Tagaram, IK 2010, ‘Pathogenic role of Cyclooxygenase-2 in Cancer’, Journal of Health Science, vol. 56, no.5, pp. 502-516.

  El-Shahat, ME, Lotfy, M, Fahmy, L, Abouel-Nour, MF, and EL-Kenawy, AE 2004, ‘Prognostic Value of Microvessel Density, Matrix Metalloproteinase-9 and p53 Protein Expression in Esophageal Cancer’ Journal of the Egyptian Nat. Cancer.16(4) pp.224-230.

  Evoric, BM, 2005, ‘Quantitation of Microvessel density in Squamous Cell Carcinoma of the Head and Neck by Computer-aided Image Analysis’ Wien Klin

  Wochenschr. 117 (1)-20 pp. 53-57.

  Fachiroh, J, Schouten, T, Hariwiyanto, B, Paramita, DK, Harijadi, A, Haryana, SM, Ng, MH and Middeldorp, JM 2004, ‘Molecular Diversity of Epstein-Barr Virus IgG and IgA Antibody Responses in Nasopharyngeal Carcinoma: A Comparison of Indonesian, Chinese, and European Subjects’ The Journal of Infectious Diseases. 190 pp.

  53–62. Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V 2001, ‘Cyclooxygenase-2 Pathway Correlates with VEGF Expression in Head and Neck Cancer. Implications for Tumor Angiogenesis and Metastasis’. Neoplasia. 3 (1): 53-61.

  Guang-Wu, H, Sunagawa, M, Jie-En, L, Shimada, S, Gang, Z, Tokeshi, Y & Kosugi, T 2000, ‘The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF) and the extension of nasopharyngeal carcinoma’, The laryngoscope, vol. 110, pp. 2066-2069.

  Guigay, J, Temam, S, Bourhis, J, Pignon, JP. & Armand, JP 2006, ‘Nasopharyngeal Carcinoma and Therapeutic Management: The Place of Chemotherapy’ Annals of Oncology. 17 (10) pp. 304-307.

  th Guyton, AC & Hall, JE 1996, Textbook of Medical Physiology. 9 ed.

  Philadelphia : WB Saunders Company. pp. 199-208. Harahap, MPH 2009, Ekspresi Vascular Endothelial Growth Factor Pada Karsinoma Nasofaring. Tesis. Universitas Sumatera Utara.

  Her, C 2001 ‘Nasopharyngeal Cancer and the Southeast Asian Patient’ American Family Physician. 63 (9) pp.1776-1780. Jeyakumar, A, Brickman, TM, Jeyakumar, A, & Doerr, T 2006, ‘Review of

  Nasopharyngeal Carcinoma’ Ear, Nose and Throat Journal. 85 (3) pp.168-184. Ji, B, Liu, Y, Zhang, P, Wang, Y, Wang G. 2012, ‘COX-2 Expression and

  Tumor Angiogenesis in Thyroid Carcinoma Patients among Northeast Chinese Population-Result of a Single-Center Study’ International

  Journal of Medical Sciences. 9(3) pp. 237-242

  Kumar, S 2003, ‘Epidemiological and Etiological Factors Associated with Nasopharyngeal Carcinoma. ICMR Bulletin. 33 (9) pp.1-9. Kyzas, PA, Stefanou, D dan Agnantis, NJ 2005, ‘COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma. Modern Pathology. 18 PP. 153–160

  Leahy, KM, Koki, AT and Masferrer, JL. 2000 ‘Role of Cyclooxygenases in Angiogenesis’ Medicinal Chemistry.7. pp. 1163-1170 Levita J, Istyastono EP, Nawawi A, Mutholib A, Esch IJP & Ibrahim S.

  ‘

  2009 Analyzing the Interaction of Andrographolide and Neoandrographolide, Diterpenoid Compounds From Andrographis

  

Paniculata (Burm.F) nees, to Cyclooxygenase-2 Enzyme by Docking

Simulation’. ITB J. Sci. 41 A (2): 110-9.

  Lin, JC,Chen, KY, Wang, WY, Jan, JS Liang, WM & Wei, YH 2002, ‘Evaluation of cytokeratine 19 mRNA as a tumor marker in the periheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy’ Int. J. Cancer, 97, pp. 548-53. Mandriota, SJ, Jussila, L, Jeltsch, M, Compagni, A, Baetens, D, Prevo, R,

  Banerji, S, Huarte, J, Montesano, R, Jackson, DG, Orci, L, Alitalo, K, Christofori, G & Pepper, MS 2001, ‘Vascular endothelial growth factor- C-mediated lymphangiogenesis promotes tumour metastasis’, EMBO _, Journal vol. 20, no. 4, pp. 672-682.

  Murono S, Inoue H, Tanabe T, Joab I, Yoshizaki T, Furukawa M 2001, ‘Induction of Cyclooxygenase-2 by Epstein - Barr virus Latent Membrane Protein 1 is involved in Vascular Endothelial Growth Factor Production in Nasopharyngeal Carcinoma Cells’. PNAS. 98 (12): 6905- 10.

  2007, ‘COX-2 expression in invasive breast cancer: correlation with prognostic parameters and outcome’, Appl Immunohistochem Mol

  Morphol, vol.15, no.3, pp. 255-9.

  Natonal Comprehensive Cancer Network. 2010. NCCN Clinical Practise Guidelines in Oncology Head And Neck Cancer. Nishida, N, Yano, H, Nishida, T, Kamura, T, Kojiro, M 2006,

  ‘Angiogenesis in Cancer. Vascular Health and Risk Management. 2 (3) pp. 213-219. Pang RWC. & Poon, RTP 2006, ‘Clinical Implications of Angiogenesis in Cancers’ Vascular Health and Risk Management. 2 (2) pp. 97-108. Poon, RT, Ng, IO, Lau, C, Yu, W, Yang, Z, Fan, S and Wong, J 2002,

  ‘Tumor microvessel density as a Predictor Recurrence After Resection of Hepatocellular Carcinoma : A Prospective Study’ Journal of Clinical

  Oncology. 20 (7) pp. 1775 – 1785.

  Puspitasari, D 2011 Gambaran Karsinoma Nasofaring di RSUP H. Adam Malik Medan Tahun 2006-2010. Tesis. Universitas Sumatera Utara. Rao, VUS, Shenoy, AM, & Karthikeyan, B 2011, ‘Role of angiogenetic markers to predict neck node metastasis in head and neck’ J Cancer

  Res Ther. 6(2) pp. 142-6.

  Rishikesh MK & Sadhana SS 2003, ‘Protaglandins and Cyclooxygenase: Their Probable Role in Cancer’. Indian Journal of Pharmacology. 35: 3-12.

  Roychowdhury, DF, Tseng, A, Fu, KK, Weinberg, V, & Weidner, N 1996, ‘New Prognostic Factors in Nasopharyngeal Carcinoma’. American Cancer Society. 77 (8) pp. 1419- 1426.

  Rubio, L, 2002, ‘Expression of p53 Protein and Tumor Angiogenesis as Prognostic Factors in Nasopharyngeal Carcinoma Patients. Pathol Rest Prac. 198 (2) pp. 97-102.

  Siregar, SM 2010, Hubungan EBNA-1 dengan Karsinoma Nasofaring di RSUP H. Adam Malik Medan. Tesis. Universitas Sumatera Utara. Sobolewski, C, Cerella, C, Dicato, M, Ghibelli, L, Diederich, M. 2010.’ The

  Role of Cyclooxygenase-2 inCell Proliferation and Cell Death in Human Malignancies. International Journal of Cell Biologi. pp.1-21. Sari, VA 2004 ‘Korelasi tingkat ekspresi cyclooxygenase-2 dan gambaran angiogenesis pada karsinoma nasofaring tak berdiferensiasi’ Tesis.

  Program Pendidikan Dokter Spesialis Ilmu Penyakit THT FKUI. Jakarta. Segawa Y, Yamamoto H, Shiratsuchi H, Hirakawa N, Komune S & Tsuneyoshi M 2009, ‘Close correlation between CXCR4 and VEGF expression and their prognostic implications in nasopharyngeal carcinoma’ Sudyartono, T & Wiratno 1996, ‘Manifestasi Klinik sebagai Dasar

  Diagnosis Karsinoma Nasofaring. PIT PERHATI. Malang: PERHATI, pp. 841-859. Tae, K, El-Naggar, AK, Yoo, E, Feng, L, Lee, JJ, Hong, WK, Hittelman,

  WN, Shin, DM 2000, ‘Expression of Vascular Endothelial Growth Factor and Microvessel Density in Head and Neck Tumorigenesis’.

  Clinical Cancer Research. 6 pp. 2821–2828

   TC 2005, ‘Cyclooxygenase 2 expression in nasopharyngeal carcinoma: immunohistochemical findings and potential implications’ J Clin Pathol.58(5) pp. 535–8

  Taweevisit, M, Keelawat, S & Thoner PS 2010, ‘Correlation of Microvascular Density and Proliferation Index in Undifferentiated Nasopharyngeal Carcinoma. Asian Biomedicine, 4 (2) pp. 315-321.

  Uzzan, B, Nicholas, P, Cucherat M, & Perret, GI 2004, ‘Microvessel

  

density as A Prognostic Factor in Women with Breast Cancer : A

  Systematic Review of the Literature and Meta-Analysis. Cancer researches. 64 pp. 2941-2955. Wei, WI 2006, ‘Nasopharyngeal Cancer’ In : Bailey, B.J., Johnson, J.T.,

  th Newlands, S.D. (eds) Head & Neck Surgery Otolaryngology. 4 ed.

  Philadelphia: Lippincott Williams & Wilkins. pp. 1657-1671. Weidner N, Semple JP, Welch WR & Folkman J 1991, ‘Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma’

  The new England journal of medicine. 324(1) pp. 1-7. Wu, AWJ, Gu, FJ, Ji, FZ, Li, and Xu, GW 2003. ‘Role of COX-2

  Carcinogenesis of Colorectal Ca ncer and it’s Relationship with Tumor Biological Characteristic and Patients Prognosis. World J.

  Gastroenterol. 14 (10) pp. 256-265. Wu, AW, Gu, J, Li, ZF, Ji, JF, Xu, GW 2004, ‘COX-2 expression and tumor angiogenesis in colorectal cancer World J Gastroenterol. 10(16) pp. 2323-2326

   Y 2006, ‘Expression of Cyclooxygenase-2 in Nasopharyngeal Carcinoma and Its Relation to Angiogenesis and Prognosis’. 5(2) , pp. 104-107.

  Yeh, SA, Tang, Y, Lui, CC, & Huang, EY 2006, ‘Treatment Outcomes of Patients with AJCC Stage IVC Nasopharyngeal Carcinoma: Benefits of Primary Radiotherapy. Jpn J Clin Onco. 36 (3) pp. 132-136.

  Zhao, HC, Qin, R, Chen, X, Sheng, X, Wu, J, Wang, D, Chen GH 2006, ‘Microvessel density is a Prognostic Marker of Human Gastric Cancer’ World Journals of Gastroenterology. 12 (47) pp .7598-7603.